Annual revenue:
$50.29B+$4.85B(+10.67%)Summary
- As of today (August 22, 2025), NVS annual revenue is $50.29 billion, with the most recent change of +$4.85 billion (+10.67%) on December 31, 2024.
- During the last 3 years, NVS annual revenue has fallen by -$1.34 billion (-2.59%).
- NVS annual revenue is now -13.23% below its all-time high of $57.96 billion, reached on December 31, 2011.
Performance
NVS Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$14.28B+$1.05B(+7.91%)Summary
- As of today (August 22, 2025), NVS quarterly revenue is $14.28 billion, with the most recent change of +$1.05 billion (+7.91%) on June 30, 2025.
- Over the past year, NVS quarterly revenue has increased by +$1.77 billion (+14.13%).
- NVS quarterly revenue is now -11.16% below its all-time high of $16.07 billion, reached on June 30, 2011.
Performance
NVS Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$53.40B+$1.77B(+3.42%)Summary
- As of today (August 22, 2025), NVS TTM revenue is $53.40 billion, with the most recent change of +$1.77 billion (+3.42%) on June 30, 2025.
- Over the past year, NVS TTM revenue has increased by +$5.85 billion (+12.30%).
- NVS TTM revenue is now -13.99% below its all-time high of $62.08 billion, reached on September 30, 2011.
Performance
NVS TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
NVS Revenue Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +10.7% | +14.1% | +12.3% |
3 y3 years | -2.6% | +11.7% | +3.5% |
5 y5 years | +5.9% | +25.9% | +10.8% |
NVS Revenue Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -2.6% | +19.1% | at high | +36.1% | at high | +23.3% |
5 y | 5-year | -2.6% | +19.1% | at high | +36.1% | at high | +23.3% |
alltime | all time | -13.2% | +165.0% | -11.2% | +233.8% | -14.0% | +837.3% |
NVS Revenue History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | $14.28B(+7.9%) | $53.40B(+3.4%) |
Mar 2025 | - | $13.23B(+1.3%) | $51.63B(+2.8%) |
Dec 2024 | $50.29B(+10.7%) | $13.06B(+1.8%) | $50.22B(+3.4%) |
Sep 2024 | - | $12.82B(+2.5%) | $48.59B(+2.2%) |
Jun 2024 | - | $12.51B(+5.8%) | $47.55B(+2.3%) |
Mar 2024 | - | $11.83B(+3.6%) | $46.46B(+2.2%) |
Dec 2023 | $45.44B(+7.7%) | $11.42B(-3.0%) | $45.46B(+1.9%) |
Sep 2023 | - | $11.78B(+3.1%) | $44.61B(+3.0%) |
Jun 2023 | - | $11.43B(+5.6%) | $43.32B(-3.0%) |
Mar 2023 | - | $10.82B(+2.3%) | $44.67B(-3.7%) |
Dec 2022 | $42.21B(-18.2%) | $10.58B(+0.8%) | $46.38B(-5.4%) |
Sep 2022 | - | $10.49B(-17.9%) | $49.03B(-4.9%) |
Jun 2022 | - | $12.78B(+2.0%) | $51.57B(-0.3%) |
Mar 2022 | - | $12.53B(-5.3%) | $51.75B(+0.2%) |
Dec 2021 | $51.63B(+6.1%) | $13.23B(+1.5%) | $51.63B(+0.9%) |
Sep 2021 | - | $13.03B(+0.6%) | $51.17B(+1.5%) |
Jun 2021 | - | $12.96B(+4.4%) | $50.40B(+3.3%) |
Mar 2021 | - | $12.41B(-2.8%) | $48.79B(+0.3%) |
Dec 2020 | $48.66B(+2.4%) | $12.77B(+4.2%) | $48.66B(+0.8%) |
Sep 2020 | - | $12.26B(+8.0%) | $48.29B(+0.2%) |
Jun 2020 | - | $11.35B(-7.6%) | $48.20B(-0.9%) |
Mar 2020 | - | $12.28B(-1.0%) | $48.62B(+2.4%) |
Dec 2019 | $47.50B(+5.9%) | $12.40B(+1.9%) | $47.50B(+1.9%) |
Sep 2019 | - | $12.17B(+3.5%) | $46.60B(+2.5%) |
Jun 2019 | - | $11.76B(+5.4%) | $45.47B(+0.9%) |
Mar 2019 | - | $11.16B(-3.0%) | $45.06B(+0.5%) |
Dec 2018 | $44.83B(-8.7%) | $11.50B(+4.1%) | $44.83B(-3.1%) |
Sep 2018 | - | $11.04B(-2.8%) | $46.25B(-2.9%) |
Jun 2018 | - | $11.36B(+3.9%) | $47.62B(-1.8%) |
Mar 2018 | - | $10.93B(-15.4%) | $48.50B(-1.2%) |
Dec 2017 | $49.11B(+1.2%) | $12.91B(+4.0%) | $49.11B(+1.2%) |
Sep 2017 | - | $12.41B(+1.4%) | $48.52B(+0.6%) |
Jun 2017 | - | $12.24B(+6.1%) | $48.23B(-0.5%) |
Mar 2017 | - | $11.54B(-6.4%) | $48.46B(-0.1%) |
Dec 2016 | $48.52B(-1.9%) | $12.32B(+1.6%) | $48.52B(-0.4%) |
Sep 2016 | - | $12.13B(-2.8%) | $48.72B(-0.3%) |
Jun 2016 | - | $12.47B(+7.5%) | $48.85B(-0.5%) |
Mar 2016 | - | $11.60B(-7.3%) | $49.08B(-0.7%) |
Dec 2015 | $49.44B(-5.7%) | $12.52B(+2.1%) | $49.44B(-1.2%) |
Sep 2015 | - | $12.27B(-3.4%) | $50.05B(-1.5%) |
Jun 2015 | - | $12.69B(+6.1%) | $50.83B(-1.9%) |
Mar 2015 | - | $11.96B(-8.9%) | $51.80B(-4.5%) |
Dec 2014 | $52.42B(+0.6%) | $13.13B(+0.6%) | $54.23B(-0.6%) |
Sep 2014 | - | $13.05B(-4.5%) | $54.54B(+0.5%) |
Jun 2014 | - | $13.67B(-5.0%) | $54.24B(+1.0%) |
Mar 2014 | - | $14.38B(+7.0%) | $53.71B(+0.6%) |
Dec 2013 | $52.09B(-8.1%) | $13.44B(+5.4%) | $53.41B(-2.5%) |
Sep 2013 | - | $12.75B(-2.9%) | $54.80B(-1.0%) |
Jun 2013 | - | $13.13B(-6.8%) | $55.34B(-0.9%) |
Mar 2013 | - | $14.09B(-5.0%) | $55.86B(+2.0%) |
Dec 2012 | $56.67B(-2.2%) | $14.83B(+11.5%) | $54.79B(+1.1%) |
Sep 2012 | - | $13.30B(-2.6%) | $54.17B(-4.8%) |
Jun 2012 | - | $13.65B(+4.8%) | $56.93B(-4.1%) |
Mar 2012 | - | $13.02B(-8.4%) | $59.35B(-3.0%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2011 | $57.96B(+15.4%) | $14.21B(-11.4%) | $61.22B(-1.4%) |
Sep 2011 | - | $16.05B(-0.2%) | $62.08B(+5.6%) |
Jun 2011 | - | $16.07B(+8.0%) | $58.81B(+9.0%) |
Mar 2011 | - | $14.88B(-1.3%) | $53.93B(+5.4%) |
Dec 2010 | $50.22B(+13.9%) | $15.08B(+18.0%) | $51.18B(+2.8%) |
Sep 2010 | - | $12.78B(+14.1%) | $49.79B(+3.7%) |
Jun 2010 | - | $11.19B(-7.7%) | $48.01B(+1.4%) |
Mar 2010 | - | $12.13B(-11.4%) | $47.37B(+5.4%) |
Dec 2009 | $44.10B(+6.4%) | $13.69B(+24.4%) | $44.95B(+8.7%) |
Sep 2009 | - | $11.00B(+4.2%) | $41.34B(+0.2%) |
Jun 2009 | - | $10.55B(+8.7%) | $41.27B(-0.5%) |
Mar 2009 | - | $9.71B(-3.6%) | $41.47B(+0.2%) |
Dec 2008 | $41.46B(+8.9%) | $10.08B(-7.8%) | $41.38B(+0.4%) |
Sep 2008 | - | $10.93B(+1.6%) | $41.24B(+3.3%) |
Jun 2008 | - | $10.76B(+11.8%) | $39.92B(+3.6%) |
Mar 2008 | - | $9.62B(-3.1%) | $38.54B(+0.3%) |
Dec 2007 | $38.07B(+10.7%) | $9.93B(+3.3%) | $38.42B(+1.4%) |
Sep 2007 | - | $9.61B(+2.6%) | $37.89B(+2.1%) |
Jun 2007 | - | $9.37B(-1.5%) | $37.10B(+2.7%) |
Mar 2007 | - | $9.51B(+1.2%) | $36.14B(+4.2%) |
Dec 2006 | $34.39B(+10.9%) | $9.40B(+6.5%) | $34.69B(+5.9%) |
Sep 2006 | - | $8.83B(+5.0%) | $32.74B(+1.3%) |
Jun 2006 | - | $8.41B(+4.3%) | $32.33B(+2.4%) |
Mar 2006 | - | $8.06B(+8.2%) | $31.57B(+1.6%) |
Dec 2005 | $31.00B(+10.4%) | $7.45B(-11.5%) | $31.06B(-1.5%) |
Sep 2005 | - | $8.41B(+10.0%) | $31.53B(+4.2%) |
Jun 2005 | - | $7.65B(+1.3%) | $30.25B(+2.3%) |
Mar 2005 | - | $7.55B(-4.6%) | $29.57B(+2.1%) |
Dec 2004 | $28.09B(+13.8%) | $7.91B(+11.0%) | $28.95B(+3.7%) |
Sep 2004 | - | $7.13B(+2.3%) | $27.92B(+3.4%) |
Jun 2004 | - | $6.97B(+0.6%) | $27.01B(+1.7%) |
Mar 2004 | - | $6.93B(+0.8%) | $26.55B(+3.2%) |
Dec 2003 | $24.68B(+18.5%) | $6.88B(+10.7%) | $25.72B(+5.4%) |
Sep 2003 | - | $6.22B(-4.6%) | $24.40B(+3.6%) |
Jun 2003 | - | $6.51B(+6.7%) | $23.56B(+5.9%) |
Mar 2003 | - | $6.10B(+9.6%) | $22.24B(+6.5%) |
Dec 2002 | $20.83B(+9.8%) | $5.57B(+3.6%) | $20.88B(+2.4%) |
Sep 2002 | - | $5.37B(+3.5%) | $20.38B(+2.6%) |
Jun 2002 | - | $5.19B(+9.5%) | $19.86B(+2.8%) |
Mar 2002 | - | $4.74B(-6.6%) | $19.32B(+1.8%) |
Dec 2001 | $18.97B(-10.5%) | $5.07B(+4.6%) | $18.98B(-6.1%) |
Sep 2001 | - | $4.85B(+4.4%) | $20.22B(-0.1%) |
Jun 2001 | - | $4.65B(+5.6%) | $20.25B(+1.9%) |
Mar 2001 | - | $4.40B(-30.3%) | $19.88B(-6.1%) |
Dec 2000 | $21.19B(-1.8%) | $6.31B(+29.4%) | $21.17B(+42.5%) |
Sep 2000 | - | $4.88B(+14.1%) | $14.86B(+48.9%) |
Jun 2000 | - | $4.28B(-24.9%) | $9.97B(+75.1%) |
Mar 2000 | - | $5.70B | $5.70B |
Dec 1999 | $21.59B(-1.3%) | - | - |
Dec 1998 | $21.88B(+1.8%) | - | - |
Dec 1997 | $21.49B(-26.7%) | - | - |
Dec 1996 | $29.32B(-3.6%) | - | - |
Dec 1995 | $30.43B(+9.7%) | - | - |
Dec 1994 | $27.75B(+8.6%) | - | - |
Dec 1993 | $25.54B | - | - |
FAQ
- What is Novartis AG annual revenue?
- What is the all time high annual revenue for Novartis AG?
- What is Novartis AG annual revenue year-on-year change?
- What is Novartis AG quarterly revenue?
- What is the all time high quarterly revenue for Novartis AG?
- What is Novartis AG quarterly revenue year-on-year change?
- What is Novartis AG TTM revenue?
- What is the all time high TTM revenue for Novartis AG?
- What is Novartis AG TTM revenue year-on-year change?
What is Novartis AG annual revenue?
The current annual revenue of NVS is $50.29B
What is the all time high annual revenue for Novartis AG?
Novartis AG all-time high annual revenue is $57.96B
What is Novartis AG annual revenue year-on-year change?
Over the past year, NVS annual revenue has changed by +$4.85B (+10.67%)
What is Novartis AG quarterly revenue?
The current quarterly revenue of NVS is $14.28B
What is the all time high quarterly revenue for Novartis AG?
Novartis AG all-time high quarterly revenue is $16.07B
What is Novartis AG quarterly revenue year-on-year change?
Over the past year, NVS quarterly revenue has changed by +$1.77B (+14.13%)
What is Novartis AG TTM revenue?
The current TTM revenue of NVS is $53.40B
What is the all time high TTM revenue for Novartis AG?
Novartis AG all-time high TTM revenue is $62.08B
What is Novartis AG TTM revenue year-on-year change?
Over the past year, NVS TTM revenue has changed by +$5.85B (+12.30%)